Santa Clara, CA, United States of America

Jian Jeffrey Chen

This inventor holds 64 USPTO granted patents and 18 published patent applications, plus 2 CIPO patents and 10 EPO patents, primarily in Cancer Inhibitors (CPC class C07D). Top assignees: Amgen Inc., Syntex (u.s.a.) Inc., Agouron Pharmaceuticals, Inc.. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Jeffrey Chen. Retrieved from https://idiyas.com/inventor/jian-jeffrey-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 64 (Patent Applications = 18)

% Patents Active = 78.1

CIPO Patents = 2 (Patent Applications = 10)

EPO Patents = 10 (Patent Applications = 18)

Average Co-Inventor Count = 7.6

ph-index = 12

Forward Citations = 408(Granted Patents)

Forward Citations (Not Self Cited) = 356(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Santa Clara, CA (US) (1998 - 2008)
Newbury Park, CA (US) (2005 - 2011)
Camarillo, CA (US) (2013 - 2024)
Thousand Oaks, CA (US) (2019 - 2024)
San Diego, CA (US) (2023 - 2024)

Company Filing History:

Agouron Pharmaceuticals, Inc.

Scripps Research Institute

patents

7. 1 out of 5,026

Hoffmann-La Roche Inc.

9. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

KIF18A Inhibitors

KRAS G12C Inhibitors

PDE10 Inhibitors

Beta-Secretase Inhibitors

TRPM8 Antagonists

P38 Kinase Inhibitors

Substituted Piperazines

Heterobicyclic Compounds

Amino-Oxazines

Substituted Pyrimidine Compounds

Cyclopropyl Fused Thiazine Derivatives

Spiro-Tricyclic Ring Compounds

64 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12758557 - Small molecule regulators of alveolar type 2 cell proliferation for the treatment of pulmonary diseases (2026-10-13),

2. 12540129 - KIF18A inhibitors (2026-02-03),

3. 12509442 - KIF18A inhibitors (2025-12-30),

4. 12459932 - KIF18A inhibitors (2025-11-04),

5. 12441736 - KIF18A inhibitors (2025-10-14),

6. 12441705 - KIF18A inhibitors (2025-10-14),

7. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),

8. 12083121 - Substituted piperazines as KRAS G12C inhibitors (2024-09-10),

9. 12054476 - KIF18A inhibitors (2024-08-06),

10. 11905281 - KRAS G12C inhibitors and methods of using the same (2024-02-20),

11. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),

12. 11708348 - Protease inhibitors for treatment of coronavirus infections (2023-07-25),

13. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),

14. 11236069 - KIF18A inhibitors (2022-02-01),

15. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),

Title: The Innovative Journey of Jian Jeffrey Chen

Introduction: Jian Jeffrey Chen, a pioneering inventor based in Santa Clara, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Jian Jeffrey Chen holds several patents in the areas of artificial intelligence, machine learning, and robotics, with his most recent patent focusing on a revolutionary autonomous drone technology that is set to transform the logistics industry.

Career Highlights: With a background in computer science and engineering, Jian Jeffrey Chen has had a distinguished career working for leading tech companies in Silicon Valley, where he has spearheaded research and development projects that have pushed the boundaries of innovation.

Collaborations: Throughout his career, Jian Jeffrey Chen has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide, fostering a culture of innovation and knowledge sharing.

Conclusion: Jian Jeffrey Chen's relentless pursuit of innovation and his passion for creating cutting-edge technologies have solidified his reputation as a visionary inventor in the tech industry, with his work continuing to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.